The interaction between steroid hormones, human papillomavirus type 16, E6 oncogene expression, and cervical cancer

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 834-842

  Moodley, M ^a   Sewart, S ^b   Herrington, C S ^b   Chetty, R ^a   Pegoraro, R ^a   Moodley, J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cervical cancer; HPV 16 e6 oncogene; Steroid hormones

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; MEDROXYPROGESTERONE ACETATE; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; FEMALE; GENE EXPRESSION; GYNECOLOGIC CANCER; HISTOLOGY; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; WART VIRUS TYPE 16;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CONTRACEPTIVE AGENTS, FEMALE; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 1242271999     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13380.x     Document Type: Article

References (36)

1. Parkin DM, Lara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;4:184-97.
2. Sitas F, Levin CV, Spencer D et al. HIV and cancer in South Africa. S Afr Med J 1993;83:880-1.
3. Mati JKG, Mbungua S, Wander P. Cervical cancer in Kenya: Prospects for early detection at primary level. Int J Gynaecol Obstet 1994;47:261-7.
4. Lowe D, Jorizo J, Chipangwi J, Hutt MSR. Cervical carcinoma in Malawi. a histological study of 460 cases. Cancer 1981;47:2493-5.
5. Ojwang SBO, Mati JKG. Carcinoma of the cervix in Kenya. East Afr Med J 1978;55:194-198.
6. Rogo KO, Omanyi J, Onyango JN et al. Carcinoma of the cervix in the African setting. Int J Gynecol Obstet 1980;33:249-55.
7. Brinton LA. Epidemiology of cervical cancer - overview. In: Munoz, N, Bosch, FX, Shah, KV, Meheus, A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus (IARC Scientific Publications No 119), Lyon: International Agency for Research on Cancer, 1992:3-52.
8. Moodley M, Moodley J, Kleinschmidt I. Invasive cervical cancer and human immunodeficiency virus infection: a South African perspective. Int J Gynecol Cancer 2001;11:194-7.
9. Bosch FX, Manos MM, Munoz N et al. The international biological study on cervical cancer (IBSCC) study group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
10. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
11. Kjaer SK, van den Brule AJC, Brock JE et al. Human papillomavirus, the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6.
12. Herrington CS. Human papillomaviruses and cervical neoplasia I. Virology, classification, pathology and epidemiology. J Clin Pathol 1994;47:1066-72.
13. Lechner MS, Mack DH, Finicle AB, Crook T, Voudsen KH, Laimins LA. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 1992;11:3045-52.
14. Keen N, Elston R, Crawford L. Interaction of the E6 protein of human papillomavirus with cellular proteins. Oncogene 1994;9:1493-9.
15. Boyce JG, Lu T, Nelson JH, Fruchter RG. Oral contraceptives and cervical carcinoma. Am J Obstet Gynecol 1977;128:761-6.
16. Melamed MR, Flehinger BJ. Early incidence rates of precancerous cervical lesions in women using contraceptives. Gynecol Oncol 1973;1:290-8.
17. Sandmire HF, Austin SD, Bechtel RC. Carcinoma of the cervix in oral contraceptive steroid and IUD users and non-users. Am J Obstet Gynecol 1976;125:339-45.
18. Vessey MP, Lawless M, McPherson K, Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet 1983;2:930-4.
19. Moreno V, Bosch FX, Munoz N et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicenter case-control study. Lancet 2002;359:1085-92.
20. Salazar EL, Mercado E, Sojo I, Salcedo M. Relationship between estradiol 16 alpha-hydroxylation and human papillomavirus infection in cervical cell transformation. Gynecol Endocrinol 2001;15:335-40.
21. Yuan F, Chen DZ, Liu K et al. Anti-estrogenic activities of indole-3carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999a;19:1673-80.
22. Chen DZ, Qi M, Auborn KJ, Carter TH. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplasfic cervical epithelium. J Nutr 2001;131:3294-302.
23. Strahle U, Klock G, Schutz G. A DNA sequence of 15 base-pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 1987;84:7871-5.
24. Pater A, Batyatpour M, Pater M. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progestins from oral contraceptives. Am J Obstet Gynecol 1990;162:1099-103.
25. Khare S, Pater MM, Tang SC, Pater A. Effect of glucocortoid hormones on viral gene expression, growth and dysplastic differentiation in HPV 16-immortalized ecto-cervical cells. Exp Cell Res 1997;232:353-60.
26. Yuan F, Auborn K, James C. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone. Cancer Invest 1999b;17:19-29.
27. World Health Organization Collaboration Study of Neoplasia and Steroid Contraceptives. Invasive cervical cancer and combined oral contraceptives. Br Med J 1985; 290:961-5.
28. von Knebel Doeberitz M, Spitkovsky D, Ridder R. Interaction between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer. Verhandlungen Deutschen Fur Pathologie 1997;81:233-9.
29. Stanley MA. Human papillomavirus and cervical carcinogenesis. Best Pract Res Clin Obstet Gynaecol 2001;15:663-76.
30. Manos MM, Ting Y, Wright DK et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
31. Sotlar K, Selinka H-C, Menton M, Kandoff R, Bultmann B. Detection of human papillomavirus type 16, E6.E7 oncogene transcripts in dysplastic and non-dysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol 1998;69:114-21.
32. Tokunaga K, Nakamura Y, Sakata K et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987;47:5616-9.
33. Herrero R, Brinton LA, Reeves WC et al. Injectable contraceptives and risk of invasive cervical cancer: evidence of an association. Int J Cancer 1990;46:5-7.
34. World Health Organization. Collaboration study of neoplasia and steroid contraceptives invasive squamous cell carcinomas and combined oral contraceptives. Results from a multinational study. Int J Cancer 1993;55:228-36.
35. Cornelissen MTE, Smits HL, Briet MA et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 1990;71:1243-6.
36. Madeleine MM, Daling JR, Schwartz SM et al. Human papillomavirus infection and long-term oral contraceptive use increase the risk of adenocarcinoma in-situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10:171-7.